SEHA and Tawam Hospital organize Conference Emirates Oncology

Press release

Published October 9th, 2012 - 06:36 GMT

Al Bawaba

Leading international and local oncology experts will gather to discuss best practices and the latest developments in cancer research, diagnosis and treatment at the Emirates Oncology Conference, 8-12 November, at the Emirates Palace in Abu Dhabi.

Hosted by Tawam Hospital, in collaboration with the Abu Dhabi Health Services Co. (SEHA),under the theme “Setting Higher Standards in Cancer Care”, the conference has been designed to cover the breadth of oncology from epidemiology to cancer treatment, prevention and palliative care. The main cancer themes will be breast, lung, gastrointestinal, genito-urinary, gynecological, hematological malignancies, pediatric oncology/hematology, palliative care and oncology nursing.

Dr. Mohammed Jaloudi, Chair, Emirate Oncology Conference, said: “According to the Health Authority Abu Dhabi (HAAD), cancer is the second cause of death in the UAE and the leading cause of death worldwide; this is why it is our duty to organize the Emirates Oncology Conference and bring together the best in the field to promote excellence in cancer care. The conference will feature keynote presentations from leading experts, oral and poster abstracts, panel discussions and workshops, with the key objective of sharing best practices and the latest developments in cancer research, diagnosis and treatment.”

“It is within our mission and mandate to continuously improve patient care to recognized international standards and we are very delighted to be part of the Emirates Oncology Conference,” commented Dr. Ali Abdulkarim Al Obaidli, Chief Clinical Officer at SEHA. “At SEHA, we are commitment to ensure the availability of evidence-based best practice in cancer treatment and to bringing world-class cancer care to the residents of the UAE. The Emirates Oncology Conference is a major leap forward to cancer treatment and to the healthcare sector in the UAE.”

The Emirates Oncology Conference will feature speakers and experts from the USA, United Kingdom, Australia, France, Italy, Spain, India, Japan, Germany, Kuwait, Saudi Arabia, Egypt, Lebanon, Jordan, and the United Arab Emirates.

Throughout the three-day conference, sessions will focus on key topics such as Cancer Burden in the Region, Reducing Rates of Mastectomy for Breast Cancer, Psycho‐social Interventions for Oncology Patients, Cancer Pain Management, Genetic Testing, New Treatment Options in Metastatic Colorectal Cancer, Breast Cancer in the UAE, Role of Stem Cells in Gastric Carcinogenesis, and many more. Several interactive sessions and case studies are also some of the conference’s highlights. For full conference program, visit: http://tawamhospital.ae/oncoconference/.

Tawam Hospital is part of the SEHA Health System owned and operated by Abu Dhabi Health Services Company (SEHA) which is responsible for the curative activities of all the public hospitals and clinics of the Emirate of Abu Dhabi.

Background Information

SEHA HealthSystem

SEHA is the corporate marketing name of Abu Dhabi Health Services Company, an independent public joint stock company that owns and operates all public hospitals and clinics across the emirate. ‘SEHA’ is a phonetic rendering of the Arabic word for health.

The company was established by Emiri Decree No 10 of 2007 and is a leading participant in the reform of Abu Dhabi’s healthcare sector. The reform seeks to upgrade and improve healthcare delivery to the public at a level comparable to the finest healthcare systems in the world. The program began by separating management and regulation – SEHA assumed responsibility for public healthcare centers and hospitals, while Health Authority-Abu Dhabi (HA-AD) was established to regulate the public and private sectors. The two organizations replaced the General Authority for Health Services (GAHS), previously responsible for both roles.